Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Oncternal Therapeutics, Inc. | a15-9690_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 23, 2015
GTx, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware |
|
000-50549 |
|
62-1715807 |
|
(State or Other Jurisdiction of Incorporation) |
|
(Commission File |
|
(IRS Employer Identification No.) |
|
175 Toyota Plaza 7th Floor Memphis, Tennessee |
|
38103 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (901) 523-9700
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On April 23, 2015, GTx, Inc. (the “Company”) issued a press release announcing the Company had entered into an exclusive worldwide license agreement with the University of Tennessee Research Foundation to develop its proprietary selective androgen receptor degrader (“SARD”) technology which potentially can degrade and inhibit all forms of androgen receptor, including those resistant to current therapies, in patients with progressive castration-resistant prostate cancer. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press Release issued by GTx, Inc. dated April 23, 2015 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: April 23, 2015 |
GTx, Inc. | |
|
|
| |
|
|
By: |
/s/ Henry P. Doggrell |
|
|
Name: |
Henry P. Doggrell |
|
|
Title: |
Vice President, Chief Legal Officer and Secretary |